Conditions

While it does not yet have FDA approval, researchers find novel dual SGLT-1/2 inhibitor, sotagliflozin, is efficacious and safe for patients with type 2 diabetes.

A low-calorie diet was a safe and effective treatment for individuals with newly diagnosed T2D and obesity.

Tirzepatide's dual-action may significantly impact a person's weight management and blood glucose compared to GLP-1 receptor agonists like semaglutide.

Recent trials are showing that gastrointestinal surgery may be the new cure for type 2 diabetes, but few patients have access to it.

Study shows that breastfeeding can provide diabetes inhibiting effects for over three years.

In managing type 1 diabetes, a single combined formulation of pramlintide and prandial insulin can provide multiple benefits.

Insulin icodec is a novel once-weekly basal insulin analog for patients with type 2 diabetes.

Treating obstructive sleep apnea can decrease catecholamine, increase insulin sensitivity, and decrease pancreatic beta-cell apoptosis, leading to a lower risk of developing T2D.

What if there is an adjunct option in managing type 1 diabetes beyond insulin analogs in the form of GLP-1 RAs?

Tethered combination therapy for type 2 diabetes could be more beneficial than two medications taken concurrently.